FDA Guidance and Notices, February 2025: IRB Written Procedures and Smartphone Alerts for Diabetes Devices
FDA issued only two device-related documents in February, both on the 5th. If you work on devices that pair with a smartphone, read the safety communication on diabetes device alerts first. FDA said alerts from continuous glucose monitors (CGMs), insulin pumps and similar devices may not reach patients after operating system updates, changes to notification settings or Bluetooth connection problems, and asked patients to check their alert settings regularly.
The other document is a revised final guidance on the written procedures of institutional review boards (IRBs).
Final guidance
- Institutional Review Board (IRB) Written Procedures (February 5): Issued as a revision of the earlier version.
Safety communications and other updates
- FDA Alerts Patients to Regularly Check Diabetes-Related Smartphone Device Alert Settings, Especially Following Phone Hardware or Software Changes: FDA Safety Communication (February 5): Points to OS updates, notification settings and Bluetooth connections as reasons alerts may not get through, and asks patients to recheck their settings, especially after changing phone hardware or software. FDA says it is working with manufacturers on ongoing testing and communication.
Note: dates are FDA issue dates or Federal Register publication dates. Linked pages may now show a later version.
RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.
← All articles